¨. O. Asar, J. Ritchie, P. A. Kalra, and P. J. Diggle, Joint modelling of repeated measurement and time-to-event data: an introductory tutorial, International Journal of Epidemiology, vol.44, issue.1, pp.334-344, 2015.
DOI : 10.1093/ije/dyu262

B. Delyon, M. Lavielle, and E. Moulines, Convergence of a stochastic approximation version of the em algorithm, Annals of Statistics, vol.27, pp.94-128, 1999.

S. Desmée, F. Mentré, C. Veyrat-follet, and J. Guedj, Nonlinear Mixed-Effect Models for Prostate-Specific Antigen Kinetics and Link with Survival in the Context of Metastatic Prostate Cancer: a Comparison by Simulation of Two-Stage and Joint Approaches, The AAPS Journal, vol.17, issue.3, pp.691-699, 2015.
DOI : 10.1208/s12248-015-9745-5

A. Garcia-hernandez, D. Rizopoulos, J. Com-guedj, R. Thiébaut, C. et al., %JM Macro v2.01 Reference Manual Available at: www.jm-macro Joint modeling of the clinical progression and of the biomarkers' dynamics using a mechanistic model, Biometrics, vol.67, pp.59-66, 2011.

X. Guo and B. P. Carlin, Separate and Joint Modeling of Longitudinal and Event Time Data Using Standard Computer Packages, The American Statistician, vol.58, issue.1, pp.16-24, 2004.
DOI : 10.1198/0003130042854

R. S. Herbst and F. R. Khuri, Mode of action of docetaxel ??? a basis for combination with novel anticancer agents, Cancer Treatment Reviews, vol.29, issue.5, pp.407-415, 2003.
DOI : 10.1016/S0305-7372(03)00097-5

E. Kuhn and M. Lavielle, Maximum likelihood estimation in nonlinear mixed effects models, Computational Statistics & Data Analysis, vol.49, issue.4, pp.1020-1038, 2005.
DOI : 10.1016/j.csda.2004.07.002

M. Lavielle, A. Samson, K. Fermin, A. Mentré, and F. , Maximum Likelihood Estimation of Long-Term HIV Dynamic Models and Antiviral Response, Biometrics, vol.48, issue.1, pp.250-259, 2011.
DOI : 10.1111/j.1541-0420.2010.01422.x
URL : https://hal.archives-ouvertes.fr/inserm-00486937

C. Mbogning, K. Bleakley, and M. Lavielle, Joint modelling of longitudinal and repeated time-to-event data using nonlinear mixed-effects models and the stochastic approximation expectation???maximization algorithm, Journal of Statistical Computation and Simulation, vol.30, issue.8, pp.1512-1528, 2015.
DOI : 10.1007/s10928-012-9248-2

K. Y. Park and P. Qiu, Model selection and diagnostics for joint modeling of survival and longitudinal data with crossing hazard rate functions, Statistics in Medicine, vol.8, issue.26, pp.4532-4546, 2014.
DOI : 10.1002/sim.6259

A. S. Perelson and J. Guedj, Modelling hepatitis C therapy???predicting effects of treatment, Nature Reviews Gastroenterology & Hepatology, vol.47, issue.8, pp.437-445, 2015.
DOI : 10.1002/hep.24272

D. Petrylak, Therapeutic options in androgen-independent prostate cancer: building on docetaxel, BJU International, vol.23, issue.s2, pp.41-46, 2005.
DOI : 10.1200/JCO.2002.03.061

E. L. Plan, A. Maloney, F. Mentré, M. O. Karlsson, B. et al., Performance Comparison of Various Maximum Likelihood Nonlinear Mixed-Effects Estimation Methods for Dose???Response Models, The AAPS Journal, vol.14, issue.3, pp.420-432, 2012.
DOI : 10.1208/s12248-012-9349-2
URL : https://hal.archives-ouvertes.fr/inserm-00709829

M. Prague, D. Commenges, J. Guedj, J. Drylewicz, and R. Thiébaut, NIMROD: A program for inference via a normal approximation of the posterior in models with random effects based on ordinary differential equations, Computer Methods and Programs in Biomedicine, vol.111, issue.2, pp.447-458, 2013.
DOI : 10.1016/j.cmpb.2013.04.014
URL : https://hal.archives-ouvertes.fr/hal-00933752

C. Proust-lima, J. M. Taylor, S. G. Williams, D. P. Ankerst, N. Liu et al., Determinants of Change in Prostate-Specific Antigen Over Time and Its Association With Recurrence After External Beam Radiation Therapy for Prostate Cancer in Five Large Cohorts, International Journal of Radiation Oncology*Biology*Physics, vol.72, issue.3, pp.782-791, 2008.
DOI : 10.1016/j.ijrobp.2008.01.056
URL : https://hal.archives-ouvertes.fr/inserm-00263863

B. Ribba, N. H. Holford, P. Magni, I. Trocóniz, I. Gueorguieva et al., A Review of Mixed-Effects Models of Tumor Growth and Effects of Anticancer Drug Treatment Used in Population Analysis, CPT: Pharmacometrics & Systems Pharmacology 3, p.113, 2014.
DOI : 10.1016/j.jtbi.2012.12.013

D. Rizopoulos, JM: An R package for the joint modelling of longitudinal and time-to-event data, Journal of Statistical Software, vol.35, pp.1-33, 2010.

D. Rizopoulos, Dynamic Predictions and Prospective Accuracy in Joint Models for Longitudinal and Time-to-Event Data, Biometrics, vol.63, issue.9, pp.819-829, 2011.
DOI : 10.1111/j.1541-0420.2010.01546.x

D. Rizopoulos, Joint Models for Longitudinal and Time-to- Event Data: With Applications in R, Boca Raton, vol.20121833, 2012.
DOI : 10.1201/b12208

D. Rizopoulos, G. Verbeke, and E. Lesaffre, Fully exponential Laplace approximations for the joint modelling of survival and longitudinal data, Journal of the Royal Statistical Society: Series B (Statistical Methodology), vol.11, issue.3, pp.637-654, 2009.
DOI : 10.1111/j.1467-9868.2008.00704.x

A. Ruffion, X. Rebillard, and F. Grima, Psa doubling time and method of calculation. Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise, pp.1035-1041, 2005.

S. `-ene, M. Bellera, C. A. Proust-lima, and C. , Shared random-effect models for the joint analysis of longitudinal and time-to-event data: Application to the prediction of prostate cancer recurrence, pp.134-155, 2014.

B. Seruga, A. Ocana, and I. F. Tannock, Drug resistance in metastatic castration-resistant prostate cancer, Nature Reviews Clinical Oncology, vol.11, issue.1, pp.12-23, 2011.
DOI : 10.1038/nrclinonc.2010.136

W. D. Stein, W. D. Figg, W. Dahut, A. D. Stein, M. B. Hoshen et al., Tumor Growth Rates Derived from Data for Patients in a Clinical Trial Correlate Strongly with Patient Survival: A Novel Strategy for Evaluation of Clinical Trial Data, The Oncologist, vol.13, issue.10, pp.1046-1054, 2008.
DOI : 10.1634/theoncologist.2008-0075

I. F. Tannock, K. Fizazi, S. Ivanov, C. T. Karlsson, A. Fléchon et al., Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial, The Lancet Oncology, vol.14, issue.8, pp.760-768, 2013.
DOI : 10.1016/S1470-2045(13)70184-0

A. A. Tsiatis and M. Davidian, Joint modeling of longitudinal and time-to-event data: An overview, Statistica Sinica, vol.14, pp.809-834, 2004.

M. Vigan, J. Stirnemann, and F. Mentré, Evaluation of Estimation Methods and Power of Tests of Discrete Covariates in Repeated Time-to-Event Parametric Models: Application to Gaucher Patients Treated by Imiglucerase, The AAPS Journal, vol.16, issue.3, pp.415-423, 2014.
DOI : 10.1208/s12248-014-9575-x
URL : https://hal.archives-ouvertes.fr/inserm-00967034

M. Wilbaux, M. Tod, J. De-bono, D. Lorente, J. Mateo et al., A Joint Model for the Kinetics of CTC Count and PSA Concentration During Treatment in Metastatic Castration-Resistant Prostate Cancer, CPT: Pharmacometrics & Systems Pharmacology, pp.277-285, 2015.
DOI : 10.1002/psp4.34

L. Wu, W. Liu, G. Y. Yi, and Y. Huang, Analysis of Longitudinal and Survival Data: Joint Modeling, Inference Methods, and Issues, Article ID 640153, 2011.
DOI : 10.1214/009053605000000480

A. Armstrong, M. Eisenberger, S. Halabi, S. Oudard, D. Nanus et al., Biomarkers in the Management and Treatment of Men with Metastatic Castration-Resistant Prostate Cancer, European Urology, vol.61, issue.3, pp.549-59, 2012.
DOI : 10.1016/j.eururo.2011.11.009

A. Tsiatis and M. Davidian, Joint modeling of longitudinal and time-to-event data: an overview, Stat Sin, vol.14, pp.809-834, 2004.

L. Wu, W. Liu, G. Yi, and Y. Huang, Analysis of Longitudinal and Survival Data: Joint Modeling, Inference Methods, and Issues, Journal of Probability and Statistics, vol.57, issue.1, pp.10-1155, 2011.
DOI : 10.1214/009053605000000480

D. Rizopoulos, M. Murawska, E. Andrinopoulou, G. Molenberghs, J. Takkenberg et al., Dynamic Predictions with Time-Dependent Covariates in Survival Analysis using Joint Modeling and Landmarking, 2013.

C. Proust-lima and J. Taylor, Development and validation of a dynamic prognostic tool for prostate cancer recurrence using repeated measures of posttreatment PSA: a joint modeling approach, Biostatistics, vol.10, issue.3, pp.535-584, 2009.
DOI : 10.1093/biostatistics/kxp009
URL : https://hal.archives-ouvertes.fr/inserm-00367752

P. Blanche, C. Proust-lima, L. Loubère, C. Berr, J. Dartigues et al., Quantifying and comparing dynamic predictive accuracy of joint models for longitudinal marker and time-to-event in presence of censoring and competing risks, Biometrics, vol.68, issue.1
DOI : 10.1111/biom.12232

A. Mauguen, B. Rachet, S. Mathoulin-pélissier, G. Lawrence, S. Siesling et al., Validation of death prediction after breast cancer relapses using joint models, BMC Medical Research Methodology, vol.8, issue.9, pp.27-37, 2015.
DOI : 10.1016/S1470-2045(07)70245-0

I. Tannock, K. Fizazi, S. Ivanov, C. Karlsson, A. Fléchon et al., Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial, The Lancet Oncology, vol.14, issue.8, pp.760-768, 2013.
DOI : 10.1016/S1470-2045(13)70184-0

S. Desmée, F. Mentré, C. Veyrat-follet, B. Sébastien, and J. Guedj, Using the SAEM algorithm for mechanistic joint models characterizing the relationship between nonlinear PSA kinetics and survival in prostate cancer patients, Biometrics, vol.2012, issue.1, p.2016
DOI : 10.1111/biom.12537

S. Development and T. , Stan Modeling Language Users Guide and Reference Manual

P. Heagerty and Y. Zheng, Survival Model Predictive Accuracy and ROC Curves, Biometrics, vol.9, issue.1, pp.92-105, 2005.
DOI : 10.1093/biostatistics/kxh013

L. Parast, S. Cheng, and T. Cai, Landmark Prediction of Long-Term Survival Incorporating Short-Term Event Time Information, Journal of the American Statistical Association, vol.103, issue.500, pp.1492-501, 2012.
DOI : 10.1080/01621459.2012.721281

R. Schoop, E. Graf, and M. Schumacher, Quantifying the Predictive Performance of Prognostic Models for Censored Survival Data with Time-Dependent Covariates, Biometrics, vol.61, issue.2, pp.603-613, 2008.
DOI : 10.1111/j.1541-0420.2007.00889.x

E. Graf, C. Schmoor, W. Sauerbrei, and M. Schumacher, Assessment and comparison of prognostic classification schemes for survival data, 18<2529::AID- SIM274>3.0.CO, pp.2529-2574, 1999.

P. Blanche, A. Latouche, V. Viallon, M. Lee, M. Gail et al., Time-Dependent AUC with Right-Censored Data: A Survey, Risk Assess. Eval. Predict, vol.2013, pp.239-51
DOI : 10.1007/978-1-4614-8981-8_11
URL : https://hal.archives-ouvertes.fr/hal-00924087

T. Gerds and M. Schumacher, Consistent Estimation of the Expected Brier Score in General Survival Models with Right-Censored Event Times, Biometrical Journal, vol.93, issue.6, pp.1029-1069, 2006.
DOI : 10.1002/bimj.200610301

P. Blanche and . Package, timeROC " : time-dependent ROC curve and AUC for censored survival data, Vienna Austria R Found Stat Comput, 2013.

H. Tu, S. Jacobs, A. Borkowski, and N. Kyprianou, Incidence of apoptosis and cell proliferation in prostate cancer: Relationship with TGF-??1 and bcl-2 expression, 5<357::AID-IJC1>3.0.CO, pp.357-363, 1996.
DOI : 10.1002/(SICI)1097-0215(19961021)69:5<357::AID-IJC1>3.0.CO;2-4

T. Polascik, J. Oesterling, and A. Partin, PROSTATE SPECIFIC ANTIGEN, The Journal of Urology, vol.162, pp.293-306, 1999.
DOI : 10.1097/00005392-199908000-00003

K. Park and P. Qiu, Model selection and diagnostics for joint modeling of survival and longitudinal data with crossing hazard rate functions, Statistics in Medicine, vol.8, issue.26, pp.4532-4578, 2014.
DOI : 10.1002/sim.6259

P. K. Andersen and R. D. Gill, Cox's regression model for counting processes : a large sample study. The Annals of Statistics, pp.1100-1120, 1982.

A. R. Anderson and V. Quaranta, Integrative mathematical oncology, Nature Reviews Cancer, vol.247, issue.3, pp.227-234, 2008.
DOI : 10.1038/nrc2329

E. R. Andrinopoulou, D. Rizopoulos, M. L. Geleijnse, E. Lesaffre, A. J. Bogers et al., Dynamic prediction of outcome for patients with severe aortic stenosis: application of joint models for longitudinal and time-to-event data, BMC Cardiovascular Disorders, vol.33, issue.1, pp.1-8, 2015.
DOI : 10.1093/eurheartj/ehs109

E. R. Andrinopoulou, D. Rizopoulos, J. J. Takkenberg, and E. Lesaffre, Joint modeling of two longitudinal outcomes and competing risk data, Statistics in Medicine, vol.14, issue.5, pp.3167-3178, 2014.
DOI : 10.1002/sim.6158

G. L. Andriole, E. D. Crawford, I. R. Grubb, S. S. Buys, D. Chia et al., Mortality Results from a Randomized Prostate-Cancer Screening Trial, New England Journal of Medicine, vol.360, issue.13, pp.1310-1319, 2009.
DOI : 10.1056/NEJMoa0810696

S. Arlot and A. Celisse, A survey of cross-validation procedures for model selection, Statistics Surveys, vol.4, issue.0, pp.40-79, 2010.
DOI : 10.1214/09-SS054
URL : https://hal.archives-ouvertes.fr/hal-00407906

A. J. Armstrong, M. A. Eisenberger, S. Halabi, S. Oudard, D. M. Nanus et al., Biomarkers in the Management and Treatment of Men with Metastatic Castration-Resistant Prostate Cancer, European Urology, vol.61, issue.3, pp.549-559, 2012.
DOI : 10.1016/j.eururo.2011.11.009

Ö. Asar, J. Ritchie, P. A. Kalra, and P. J. Diggle, Joint modelling of repeated measurement and time-to-event data: an introductory tutorial, International Journal of Epidemiology, vol.44, issue.1, pp.334-344, 2015.
DOI : 10.1093/ije/dyu262

D. R. Berthold, G. R. Pond, F. Soban, R. De-wit, M. Eisenberger et al., Docetaxel Plus Prednisone or Mitoxantrone Plus Prednisone for Advanced Prostate Cancer: Updated Survival in the TAX 327 Study, Journal of Clinical Oncology, vol.26, issue.2, pp.242-245, 2008.
DOI : 10.1200/JCO.2007.12.4008

A. Bill-axelson, L. Holmberg, H. Garmo, J. R. Rider, K. Taari et al., Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer, New England Journal of Medicine, vol.370, issue.10, pp.932-942, 2014.
DOI : 10.1056/NEJMoa1311593

M. A. Björnsson, L. E. Friberg, and U. S. Simonsson, Performance of Nonlinear Mixed Effects Models in the Presence of Informative Dropout, The AAPS Journal, vol.17, issue.1, pp.245-255, 2015.
DOI : 10.1208/s12248-014-9700-x

P. Blanche, Package 'timeROC' : time-dependent ROC curve and AUC for censored survival data. Vienna, Austria : R Foundation for Statistical Computing, 2013.

P. Blanche, J. F. Dartigues, and H. Jacqmin-gadda, Review and comparison of ROC curve estimators for a time-dependent outcome with marker-dependent censoring, Biometrical Journal, vol.53, issue.Suppl 3, pp.687-704, 2013.
DOI : 10.1002/bimj.201200045

P. Blanche, A. Latouche, and V. Viallon, Time-Dependent AUC with Right-Censored Data: A Survey, Risk Assessment and Evaluation of Predictions, pp.239-251, 2013.
DOI : 10.1007/978-1-4614-8981-8_11
URL : https://hal.archives-ouvertes.fr/hal-00924087

P. Blanche, C. Proust-lima, L. Loubère, C. Berr, J. F. Dartigues et al., Quantifying and comparing dynamic predictive accuracy of joint models for longitudinal marker and time-to-event in presence of censoring and competing risks, Biometrics, vol.68, issue.1, pp.102-113, 2015.
DOI : 10.1111/biom.12232

P. L. Bonate and B. Suttle, Effect of Censoring Due to Progressive Disease on Tumor Size Kinetic Parameter Estimates, The AAPS Journal, vol.15, issue.3, pp.832-839, 2013.
DOI : 10.1208/s12248-013-9487-1

G. W. Brier, VERIFICATION OF FORECASTS EXPRESSED IN TERMS OF PROBABILITY, Monthly Weather Review, vol.78, issue.1, pp.1-3, 1950.
DOI : 10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2

Y. Y. Chi and J. G. Ibrahim, Joint Models for Multivariate Longitudinal and Multivariate Survival Data, Biometrics, vol.57, issue.2, pp.432-445, 2006.
DOI : 10.1111/j.1541-0420.2005.00448.x

H. Choi, Response evaluation of gastrointestinal stromal tumors. The oncologist, pp.4-7, 2008.

J. H. Choi, M. J. Ahn, H. C. Rhim, J. W. Kim, G. H. Lee et al., Comparison of WHO and RECIST Criteria for Response in Metastatic Colorectal Carcinoma, Cancer Research and Treatment, vol.37, issue.5, pp.290-293, 2005.
DOI : 10.4143/crt.2005.37.5.290

L. Collette, T. Burzykowski, and F. H. Schröder, Prostate-specific antigen (PSA) alone is not an appropriate surrogate marker of long-term therapeutic benefit in prostate cancer trials, European Journal of Cancer, vol.42, issue.10, pp.1344-1350, 2006.
DOI : 10.1016/j.ejca.2006.02.011

E. Comets, A. Lavenu, and M. Lavielle, saemix : stochastic approximation expectation maximization SAEM algorithm. R package version 10, 2011.

D. Commenges, B. Liquet, and C. Proust-lima, Choice of Prognostic Estimators in Joint Models by Estimating Differences of Expected Conditional Kullback-Leibler Risks, Biometrics, vol.57, issue.2, pp.380-387, 2012.
DOI : 10.1111/j.1541-0420.2012.01753.x

D. R. Cox, Regression models and life tables (with discussion), Journal of the Royal Statistical Society, vol.34, pp.187-220, 1972.
DOI : 10.1007/978-1-4612-4380-9_37

U. G. Dafni and A. A. Tsiatis, Evaluating Surrogate Markers of Clinical Outcome When Measured with Error, Biometrics, vol.54, issue.4, pp.1445-1462, 1998.
DOI : 10.2307/2533670

M. A. Dall-'era, P. C. Albertsen, C. Bangma, P. R. Carroll, H. B. Carter et al., Active surveillance for prostate cancer : a systematic review of the literature, European Urology, vol.62, pp.976-983, 2012.

D. Amico, A. V. Whittington, R. Malkowicz, S. B. Schultz, D. Blank et al., Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer, JAMA, vol.280, issue.11, pp.969-974, 1998.
DOI : 10.1001/jama.280.11.969

C. Dartois, K. Brendel, E. Comets, C. Laffont, C. Laveille et al., Overview of model-building strategies in population PK/PD analyses: 2002???2004 literature survey, British Journal of Clinical Pharmacology, vol.4, issue.5, pp.603-612, 2007.
DOI : 10.1007/s10928-006-9046-9
URL : https://hal.archives-ouvertes.fr/inserm-00159122

J. S. De-bono, S. Oudard, M. Ozguroglu, S. Hansen, J. P. Machiels et al., Prednisone plus cabazitaxel or mitoxantrone for metastatic castrationresistant prostate cancer progressing after docetaxel treatment : a randomised openlabel trial. The Lancet, pp.1147-1154, 2010.

J. S. De-bono, H. I. Scher, R. B. Montgomery, C. Parker, M. C. Miller et al., Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer, Clinical Cancer Research, vol.14, issue.19, pp.6302-6309, 2008.
DOI : 10.1158/1078-0432.CCR-08-0872

F. De-charry, O. Colomban, B. You, A. Ruffion, P. Paparel et al., Identification of the most aggressive carcinomas among patients diagnosed with prostate cancers using mathematical modeling of PSA growth, Clinical Genitourinary Cancer, p.2015

B. Delyon, M. Lavielle, and E. Moulines, Convergence of a stochastic approximation version of the EM algorithm, Annals of Statistics, vol.27, pp.94-128, 1999.

A. P. Dempster, N. M. Laird, and D. B. Rubin, Maximum likelihood from incomplete data via the EM algorithm, Journal of the Royal Statistical Society Series B (methodological), vol.39, pp.1-38, 1977.

H. Easwaran, H. C. Tsai, and S. B. Baylin, Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance, Molecular Cell, vol.54, issue.5, pp.716-727, 2014.
DOI : 10.1016/j.molcel.2014.05.015

E. Eisenhauer, P. Therasse, J. Bogaerts, L. Schwartz, D. Sargent et al., New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1), European Journal of Cancer, vol.45, issue.2, pp.228-247, 2009.
DOI : 10.1016/j.ejca.2008.10.026

R. M. Elashoff, G. Li, and N. Li, A Joint Model for Longitudinal Measurements and Survival Data in the Presence of Multiple Failure Types, Biometrics, vol.11, issue.3, pp.762-771, 2008.
DOI : 10.1111/j.1541-0420.2007.00952.x

P. M. Enriquez-navas, J. W. Wojtkowiak, and R. A. Gatenby, Application of Evolutionary Principles to Cancer Therapy, Cancer Research, vol.75, issue.22, pp.4675-4680, 2015.
DOI : 10.1158/0008-5472.CAN-15-1337

C. L. Faucett and D. C. Thomas, SIMULTANEOUSLY MODELLING CENSORED SURVIVAL DATA AND REPEATEDLY MEASURED COVARIATES: A GIBBS SAMPLING APPROACH, Statistics in Medicine, vol.15, issue.15, pp.1663-1685, 1996.
DOI : 10.1002/(SICI)1097-0258(19960815)15:15<1663::AID-SIM294>3.0.CO;2-1

J. Ferlay, H. R. Shin, F. Bray, D. Forman, C. Mathers et al., Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008, International Journal of Cancer, vol.8, issue.19, pp.2893-2917, 2008.
DOI : 10.1002/ijc.25516

J. Ferlay, I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers et al., Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012, International Journal of Cancer, vol.13, issue.5, pp.359-386, 2015.
DOI : 10.1002/ijc.29210

J. Ferlay, I. Soerjomataram, M. E. Dikshit, R. Eser, S. Mathers et al., Cancer Incidence and Mortality Worldwide : IARC CancerBase No, International Agency for Research on Cancer, 2013.

L. Ferrer, V. Rondeau, J. J. Dignam, T. Pickles, H. Jacqmin-gadda et al., Joint modelling of longitudinal and multi-state processes: application to clinical progressions in prostate cancer, Statistics in Medicine, vol.11, issue.2
DOI : 10.1002/sim.6972

J. M. Fitzpatrick, E. Banu, and S. Oudard, Prostate-specific antigen kinetics in localized and advanced prostate cancer, BJU International, vol.67, issue.Suppl., pp.578-587, 2009.
DOI : 10.1111/j.1464-410X.2009.08345.x

M. T. Fleming, M. J. Morris, G. Heller, and H. I. Scher, Post-therapy changes in PSA as an outcome measure in prostate cancer clinical trials, Nature Clinical Practice Oncology, vol.22, issue.12, pp.658-667, 2006.
DOI : 10.1038/ncponc0664

A. Garcia-hernandez and D. Rizopoulos, %JM Macro v2.01 Reference Manual. Available at : wwwjm-macrocom, 2015.

R. A. Gatenby, A change of strategy in the war on cancer, Nature, vol.5, issue.7246, pp.508-509, 2009.
DOI : 10.1038/459508a

Z. Ge, P. J. Bickel, and J. A. Rice, An approximate likelihood approach to nonlinear mixed effects models via spline approximation, Computational Statistics & Data Analysis, vol.46, issue.4, pp.747-776, 2004.
DOI : 10.1016/j.csda.2003.10.011

T. A. Gerds, T. Cai, and M. Schumacher, The Performance of Risk Prediction Models, Biometrical Journal, vol.3, issue.4, pp.457-479, 2008.
DOI : 10.1002/bimj.200810443

T. A. Gerds and M. Schumacher, Consistent Estimation of the Expected Brier Score in General Survival Models with Right-Censored Event Times, Biometrical Journal, vol.93, issue.6, pp.1029-1040, 2006.
DOI : 10.1002/bimj.200610301

G. H. Golub and J. H. Welsch, Calculation of Gauss quadrature rules, Mathematics of Computation, vol.23, issue.106, pp.221-230, 1969.
DOI : 10.1090/S0025-5718-69-99647-1

C. Gosselaar, M. J. Roobol, S. Roemeling, and F. H. Schröder, The Role of the Digital Rectal Examination in Subsequent Screening Visits in the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam, European Urology, vol.54, issue.3, pp.581-588, 2008.
DOI : 10.1016/j.eururo.2008.03.104

E. Graf, C. Schmoor, W. Sauerbrei, and M. Schumacher, Assessment and comparison of prognostic classification schemes for survival data, Statistics in Medicine, vol.307, issue.17-18, pp.2529-2545, 1999.
DOI : 10.1002/(SICI)1097-0258(19990915/30)18:17/18<2529::AID-SIM274>3.0.CO;2-5

J. Guedj, R. Thiébaut, and D. Commenges, Joint Modeling of the Clinical Progression and of the Biomarkers' Dynamics Using a Mechanistic Model, Biometrics, vol.70, issue.1, pp.59-66, 2011.
DOI : 10.1111/j.1541-0420.2010.01418.x

X. Guo and B. P. Carlin, Separate and Joint Modeling of Longitudinal and Event Time Data Using Standard Computer Packages. The American Statistician, pp.16-24, 2004.

J. A. Hanley and B. J. Mcneil, The meaning and use of the area under a receiver operating characteristic (ROC) curve., Radiology, vol.143, issue.1, pp.29-36, 1982.
DOI : 10.1148/radiology.143.1.7063747

F. E. Harrell, K. L. Lee, and D. B. Mark, MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS, Statistics in Medicine, vol.15, issue.4, pp.361-387, 1996.
DOI : 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4

P. J. Heagerty, T. Lumley, and M. S. Pepe, Time-Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker, Biometrics, vol.39, issue.2, pp.337-344, 2000.
DOI : 10.1111/j.0006-341X.2000.00337.x

P. J. Heagerty and Y. Zheng, Survival Model Predictive Accuracy and ROC Curves, Biometrics, vol.9, issue.1, pp.92-105, 2005.
DOI : 10.1093/biostatistics/kxh013

A. Heidenreich, P. A. Abrahamsson, W. Artibani, J. Catto, F. Montorsi et al., Early Detection of Prostate Cancer: European Association of Urology Recommendation, European Urology, vol.64, issue.3, pp.347-354, 2013.
DOI : 10.1016/j.eururo.2013.06.051

A. Heidenreich, P. J. Bastian, J. Bellmunt, M. Bolla, S. Joniau et al., EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent???Update 2013, European Urology, vol.65, issue.1, pp.124-137, 2014.
DOI : 10.1016/j.eururo.2013.09.046

A. Heidenreich, P. J. Bastian, J. Bellmunt, M. Bolla, S. Joniau et al., EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer, European Urology, vol.65, issue.2, pp.467-479, 2014.
DOI : 10.1016/j.eururo.2013.11.002

E. Heijnsdijk, A. Der-kinderen, E. Wever, G. Draisma, M. Roobol et al., Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer, British Journal of Cancer, vol.39, issue.11, pp.1833-1838, 2009.
DOI : 10.1023/A:1008492013196

R. Henderson, P. Diggle, and A. Dobson, Joint modelling of longitudinal measurements and event time data, Biostatistics, vol.1, issue.4, pp.465-480, 2000.
DOI : 10.1093/biostatistics/1.4.465

K. R. Hess, G. R. Varadhachary, S. H. Taylor, W. Wei, M. N. Raber et al., Metastatic patterns in adenocarcinoma, Cancer, vol.91, issue.7, pp.1624-1633, 2006.
DOI : 10.1002/cncr.21778

J. Hilden and T. A. Gerds, A note on the evaluation of novel biomarkers: do not rely on integrated discrimination improvement and net reclassification index, Statistics in Medicine, vol.62, issue.15, pp.3405-3414, 2014.
DOI : 10.1002/sim.5804

N. Holford, Simultaneous Modelling of Disease Progression and Time to Event with NONMEM. PAGE meeting, 2005.

F. Hsieh, Y. K. Tseng, and J. L. Wang, Joint Modeling of Survival and Longitudinal Data: Likelihood Approach Revisited, Biometrics, vol.14, issue.4, pp.1037-1043, 2006.
DOI : 10.1111/j.1541-0420.2006.00570.x

C. Hu and M. E. Sale, A Joint Model for Nonlinear Longitudinal Data with Informative Dropout, Journal of Pharmacokinetics and Pharmacodynamics, vol.30, issue.1, pp.83-103, 2003.
DOI : 10.1023/A:1023249510224

C. Hu, P. O. Szapary, N. Yeilding, and H. Zhou, Informative dropout modeling of longitudinal ordered categorical data and model validation: application to exposure???response modeling of physician???s global assessment score for ustekinumab in patients with psoriasis, Journal of Pharmacokinetics and Pharmacodynamics, vol.22, issue.2, pp.237-260, 2011.
DOI : 10.1007/s10928-011-9191-7

W. Hu, G. Li, and N. Li, A Bayesian approach to joint analysis of longitudinal measurements and competing risks failure time data, Statistics in Medicine, vol.33, issue.4, pp.1601-1619, 2009.
DOI : 10.1002/sim.3562

X. Huang, G. Li, R. M. Elashoff, and J. Pan, A general joint model for longitudinal measurements and competing risks survival data with heterogeneous random effects, Lifetime Data Analysis, vol.28, issue.1, pp.80-100, 2011.
DOI : 10.1007/s10985-010-9169-6

H. Hung and C. T. Chiang, Estimation methods for time-dependent AUC models with survival data, Canadian Journal of Statistics, vol.16, pp.8-26, 2010.
DOI : 10.1002/cjs.10046
URL : http://ntur.lib.ntu.edu.tw/news/agent_contract.pdf

J. G. Ibrahim, H. Chu, and L. M. Chen, Basic Concepts and Methods for Joint Models of Longitudinal and Survival Data, Journal of Clinical Oncology, vol.28, issue.16, pp.2796-2801, 2010.
DOI : 10.1200/JCO.2009.25.0654

D. Ilic, D. O-'connor, S. Green, and T. Wilt, Screening for prostate cancer: A Cochrane systematic review, Cancer Causes & Control, vol.97, issue.S2, pp.279-285, 2007.
DOI : 10.1007/s10552-006-0087-6

F. Jácome-pita, R. Sánchez-salas, E. Barret, N. Amaruch, C. Gonzalez-enguita et al., Focal therapy in prostate cancer : the current situation, Ecancermedicalscience, vol.8, 2014.

H. Jacqmin-gadda, R. Thiébaut, and J. F. Dartigues, Mod??lisation conjointe de donn??es longitudinales quantitatives et de d??lais censur??s, Revue d'??pid??miologie et de Sant?? Publique, vol.52, issue.6, pp.502-510, 2004.
DOI : 10.1016/S0398-7620(04)99090-6

A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward et al., Global cancer statistics, Global cancer statistics, pp.69-90, 2011.
DOI : 10.3322/caac.20107

E. L. Kaplan and P. Meier, Nonparametric Estimation from Incomplete Observations, Journal of the American Statistical Association, vol.37, issue.282, pp.457-481, 1958.
DOI : 10.1214/aoms/1177731566

I. D. Kaplan, R. S. Cox, and M. A. Bagshaw, A model of prostatic carcinoma tumor kinetics based on prostate specific antigen levels after radiation therapy, Cancer, vol.2, issue.2, pp.400-405, 1991.
DOI : 10.1002/1097-0142(19910715)68:2<400::AID-CNCR2820680231>3.0.CO;2-Z

K. E. Karlsson, E. L. Plan, and M. O. Karlsson, Performance of Three Estimation Methods in Repeated Time-to-Event Modeling, The AAPS Journal, vol.13, issue.1, pp.83-91, 2011.
DOI : 10.1208/s12248-010-9248-3

E. H. Kennedy, J. M. Taylor, D. E. Schaubel, and S. Williams, The effect of salvage therapy on survival in a longitudinal study with treatment by indication, Statistics in Medicine, vol.53, issue.455, pp.2569-2580, 2010.
DOI : 10.1002/sim.4017

J. P. Klein and M. L. Moeschberger, Survival analysis : techniques for censored and truncated data, 2005.
DOI : 10.1007/978-1-4757-2728-9

Y. Kobori, Y. Kitagawa, A. Mizokami, K. Komatsu, and M. Namiki, Free-to-total prostate-specific antigen (PSA) ratio contributes to an increased rate of prostate cancer detection in a Japanese population screened using a PSA level of 2.1???10.0 ng/ml as a criterion, International Journal of Clinical Oncology, vol.17, issue.3, pp.229-232, 2008.
DOI : 10.1007/s10147-007-0742-2

E. L. Korn and R. Simon, Measures of explained variation for survival data, Statistics in Medicine, vol.39, issue.5, pp.487-503, 1990.
DOI : 10.1002/sim.4780090503

A. Król, L. Ferrer, J. P. Pignon, C. Proust-lima, M. Ducreux et al., Joint model for left-censored longitudinal data, recurrent events and terminal event: Predictive abilities of tumor burden for cancer evolution with application to the FFCD 2000-05 trial, Biometrics, vol.53, issue.3, p.2016
DOI : 10.1111/biom.12490

N. Kronik, Y. Kogan, M. Elishmereni, K. Halevi-tobias, S. Vuk-pavlovi? et al., Predicting Outcomes of Prostate Cancer Immunotherapy by Personalized Mathematical Models, PLoS ONE, vol.65, issue.12, p.15482, 2010.
DOI : 10.1371/journal.pone.0015482.s001

J. S. Krumholtz, G. F. Carvalhal, C. G. Ramos, D. S. Smith, P. Thorson et al., Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features, Urology, vol.60, issue.3, pp.469-473, 2002.
DOI : 10.1016/S0090-4295(02)01875-7

M. Lavielle, Mixed effects models for the population approach : models, tasks, methods and tools, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01122873

N. J. Law, J. M. Taylor, and H. Sandler, The joint modeling of a longitudinal disease progression marker and the failure time process in the presence of cure, Biostatistics, vol.3, issue.4, pp.547-563, 2002.
DOI : 10.1093/biostatistics/3.4.547

M. F. Leitzmann and S. Rohrmann, Risk factors for the onset of prostatic cancer: age, location, and behavioral correlates, Clinical Epidemiology, vol.4, pp.1-11, 2012.
DOI : 10.2147/CLEP.S16747

S. Lheureux and F. Joly, Cabazitaxel après docétaxel, une nouvelle option dans le cancer métastatique de la prostate résistant à la castration, Bulletin du Cancer, vol.99, pp.875-880, 2012.

M. Liberko, K. Kolostova, and V. Bobek, Essentials of circulating tumor cells for clinical research and practice, Critical Reviews in Oncology/Hematology, vol.88, issue.2, pp.338-356, 2013.
DOI : 10.1016/j.critrevonc.2013.05.002

H. Lilja, D. Ulmert, and A. J. Vickers, Prostate-specific antigen and prostate cancer: prediction, detection and monitoring, Nature Reviews Cancer, vol.174, issue.4, pp.268-278, 2008.
DOI : 10.1038/nrc2351

H. Lin, B. W. Turnbull, C. E. Mcculloch, and E. H. Slate, Latent Class Models for Joint Analysis of Longitudinal Biomarker and Event Process Data, Journal of the American Statistical Association, vol.97, issue.457, pp.53-65, 2002.
DOI : 10.1198/016214502753479220

M. J. Lindstrom and D. M. Bates, Nonlinear Mixed Effects Models for Repeated Measures Data, Biometrics, vol.46, issue.3, pp.673-687, 1990.
DOI : 10.2307/2532087

L. Liu and X. Huang, Joint analysis of correlated repeated measures and recurrent events processes in the presence of death, with application to a study on acquired immune deficiency syndrome, Journal of the Royal Statistical Society: Series C (Applied Statistics), vol.69, issue.1, pp.65-81, 2009.
DOI : 10.1111/j.1467-9876.2008.00641.x

H. J. Luboldt, J. F. Schindler, and H. Rübben, Age-specific reference ranges for prostatespecific antigen as a marker for prostate cancer. EAU-EBU Ipdate Series, pp.38-48, 2007.

A. Mauguen, B. Rachet, S. Mathoulin-pélissier, G. M. Lawrence, S. Siesling et al., Validation of death prediction after breast cancer relapses using joint models, BMC Medical Research Methodology, vol.8, issue.9, p.1, 2015.
DOI : 10.1016/S1470-2045(07)70245-0

M. Murawska, D. Rizopoulos, and E. Lesaffre, A Two-Stage Joint Model for Nonlinear Longitudinal Response and a Time-to-Event with Application in Transplantation Studies, Journal of Probability and Statistics, vol.15, issue.3957, p.2012, 2012.
DOI : 10.1002/sim.3153

T. Nguyen and J. Guedj, HCV kinetic models and their implications in drug development. CPT : Pharmacometrics & Systems Pharmacology, pp.231-242, 2015.

T. T. Nguyen, J. Guedj, E. Chachaty, J. De-gunzburg, A. Andremont et al., Mathematical Modeling of Bacterial Kinetics to Predict the Impact of Antibiotic Colonic Exposure and Treatment Duration on the Amount of Resistant Enterobacteria Excreted, PLoS Computational Biology, vol.25, issue.5, p.1003840, 2014.
DOI : 10.1371/journal.pcbi.1003840.s007

S. Oudard, Progress in emerging therapies for advanced prostate cancer, Cancer Treatment Reviews, vol.39, issue.3, pp.275-289, 2013.
DOI : 10.1016/j.ctrv.2012.09.005

L. Parast, S. C. Cheng, and T. Cai, Landmark Prediction of Long-Term Survival Incorporating Short-Term Event Time Information, Journal of the American Statistical Association, vol.103, issue.500, pp.1492-1501, 2012.
DOI : 10.1080/01621459.2012.721281

D. K. Pauler and D. M. Finkelstein, Predicting time to prostate cancer recurrence based on joint models for non-linear longitudinal biomarkers and event time outcomes, Statistics in Medicine, vol.96, issue.24, pp.3897-3911, 2002.
DOI : 10.1002/sim.1392

M. J. Pencina, R. B. D-'agostino, and R. S. Vasan, Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond, Statistics in Medicine, vol.25, issue.2, pp.157-172, 2008.
DOI : 10.1002/sim.2929

M. S. Pepe, The statistical evaluation of medical tests for classification and prediction, 2003.

A. S. Perelson and J. Guedj, Modelling hepatitis C therapy???predicting effects of treatment, Nature Reviews Gastroenterology & Hepatology, vol.47, issue.8, pp.437-445, 2015.
DOI : 10.1002/hep.24272

D. Petrylak, Therapeutic options in androgen-independent prostate cancer: building on docetaxel, BJU International, vol.23, issue.s2, pp.41-46, 2005.
DOI : 10.1200/JCO.2002.03.061

D. P. Petrylak, D. P. Ankerst, C. S. Jiang, C. M. Tangen, M. H. Hussain et al., Evaluation of Prostate-Specific Antigen Declines for Surrogacy in Patients Treated on SWOG 99-16, JNCI Journal of the National Cancer Institute, vol.98, issue.8, pp.516-521, 2006.
DOI : 10.1093/jnci/djj129

J. C. Pinheiro and D. M. Bates, Approximations to the log-likelihood function in the nonlinear mixed-effects model, Journal of computational and Graphical Statistics, vol.4, pp.12-35, 1995.

J. C. Pinheiro and D. M. Bates, Mixed-effects models in S and S-plus, 2000.
DOI : 10.1007/978-1-4419-0318-1

E. L. Plan, A. Maloney, F. Mentré, M. O. Karlsson, and J. Bertrand, Performance Comparison of Various Maximum Likelihood Nonlinear Mixed-Effects Estimation Methods for Dose???Response Models, The AAPS Journal, vol.14, issue.3, pp.420-432, 2012.
DOI : 10.1208/s12248-012-9349-2
URL : https://hal.archives-ouvertes.fr/inserm-00709829

T. J. Polascik and O. J. Partin-a, PROSTATE SPECIFIC ANTIGEN, The Journal of Urology, vol.162, pp.293-306, 1999.
DOI : 10.1097/00005392-199908000-00003

D. Pouessel, S. Oudard, G. Gravis, F. Priou, L. Shen et al., Cabazitaxel dans le cancer de la prostate métastatique résistant à la castration ayant progressé pendant ou après traitement par docétaxel : l'expérience française de l'essai TROPIC, Bulletin du Cancer, vol.99, pp.731-741, 2012.

C. Proust-lima, M. Séne, J. M. Taylor, and H. Jacqmin-gadda, Joint latent class models for longitudinal and time-to-event data: A review, Statistical Methods in Medical Research, vol.57, issue.4, pp.74-90, 2014.
DOI : 10.1200/JCO.2005.12.156

C. Proust-lima and J. M. Taylor, Development and validation of a dynamic prognostic tool for prostate cancer recurrence using repeated measures of posttreatment PSA: a joint modeling approach, Biostatistics, vol.10, issue.3, pp.535-549, 2009.
DOI : 10.1093/biostatistics/kxp009
URL : https://hal.archives-ouvertes.fr/inserm-00367752

R. Team, R : A language and environment for statistical computing Technical report, R Foundation for Statistical Computing

B. Ribba, N. Holford, and F. Mentré, The Use of Model-Based Tumor-Size Metrics to Predict Survival, Clinical Pharmacology & Therapeutics, vol.2, issue.2, pp.133-135, 2014.
DOI : 10.1038/clpt.2014.111
URL : https://hal.archives-ouvertes.fr/inserm-01084276

B. Ribba, N. H. Holford, P. Magni, I. Trocóniz, I. Gueorguieva et al., A Review of Mixed-Effects Models of Tumor Growth and Effects of Anticancer Drug Treatment Used in Population Analysis, CPT Pharmacometrics Syst. Pharmacol., vol.59, issue.5, p.113, 2014.
DOI : 10.1016/j.jtbi.2012.12.013

B. Ribba, E. Watkin, M. Tod, P. Girard, E. Grenier et al., A model of vascular tumour growth in mice combining longitudinal tumour size data with histological biomarkers, European Journal of Cancer, vol.47, issue.3, pp.479-490, 2011.
DOI : 10.1016/j.ejca.2010.10.003
URL : https://hal.archives-ouvertes.fr/inria-00539594

M. K. Rivière-jourdan and F. Mentré, Package ' Mixfim' : Evaluation of the FIM in NLMEMs using MCMC, 2015.

D. Rizopoulos, JM : An R Package for the Joint Modelling of Longitudinal and Timeto-Event Data, Journal of Statistical Software, vol.35, pp.1-33, 2010.

D. Rizopoulos, Fast fitting of joint models for longitudinal and event time data using a pseudo-adaptive Gaussian quadrature rule, Computational Statistics & Data Analysis, vol.56, issue.3, pp.491-501, 2012.
DOI : 10.1016/j.csda.2011.09.007

D. Rizopoulos, Joint Models for Longitudinal and Time-to-Event Data : With Applications in R, 2012.
DOI : 10.1201/b12208

D. Rizopoulos and P. Ghosh, A Bayesian semiparametric multivariate joint model for multiple longitudinal outcomes and a time-to-event, Statistics in Medicine, vol.13, issue.12, pp.1366-1380, 2011.
DOI : 10.1002/sim.4205

D. Rizopoulos, M. Murawska, E. R. Andrinopoulou, G. Molenberghs, J. J. Takkenberg et al., Dynamic predictions with time-dependent covariates in survival analysis using joint modeling and landmarking. arXiv preprint arXiv, p.13066479, 2013.

M. Roach, G. Hanks, H. Thames, P. Schellhammer, W. U. Shipley et al., Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference, International Journal of Radiation Oncology*Biology*Physics, vol.65, issue.4, pp.965-974, 2006.
DOI : 10.1016/j.ijrobp.2006.04.029

V. Rondeau, Y. Mazroui, and J. R. Gonzalez, Package for the Analysis of Correlated Survival Data with Frailty Models Using Penalized Likelihood Estimation or Parametrical Estimation, Journal of Statistical Software, vol.47, issue.4, pp.1-28, 2012.
DOI : 10.18637/jss.v047.i04
URL : https://hal.archives-ouvertes.fr/hal-00717543

A. Ruffion, X. Rebillard, and F. Grima, PSA doubling time and method of calculation Progrés en Urologie : Journal de l'Association Française d'Urologie et de la Société Française d'Urologie, pp.1035-1041, 2005.

A. Samson, M. Lavielle, and F. Mentré, Extension of the SAEM algorithm to left-censored data in nonlinear mixed-effects model: Application to HIV dynamics model, Computational Statistics & Data Analysis, vol.51, issue.3, pp.1562-1574, 2006.
DOI : 10.1016/j.csda.2006.05.007
URL : https://hal.archives-ouvertes.fr/hal-00263506

H. I. Scher, S. Halabi, I. Tannock, M. Morris, C. N. Sternberg et al., Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group, Journal of Clinical Oncology, vol.26, issue.7, pp.1148-1159, 2008.
DOI : 10.1200/JCO.2007.12.4487

H. I. Scher, G. Heller, A. Molina, G. Attard, D. C. Danila et al., Circulating Tumor Cell Biomarker Panel As an Individual-Level Surrogate for Survival in Metastatic Castration-Resistant Prostate Cancer, Journal of Clinical Oncology, vol.33, issue.12, pp.1348-1355, 2015.
DOI : 10.1200/JCO.2014.55.3487

F. H. Schröder, J. Hugosson, S. Carlsson, T. Tammela, L. Määttänen et al., Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC), European Urology, vol.62, issue.5, pp.745-752, 2012.
DOI : 10.1016/j.eururo.2012.05.068

F. H. Schröder, J. Hugosson, M. J. Roobol, T. L. Tammela, S. Ciatto et al., Screening and Prostate-Cancer Mortality in a Randomized European Study, New England Journal of Medicine, vol.360, issue.13, pp.1320-1328, 2009.
DOI : 10.1056/NEJMoa0810084

M. Sène, C. A. Bellera, and C. Proust-lima, Shared random-effect models for the joint analysis of longitudinal and time-to-event data : application to the prediction of prostate cancer recurrence, pp.134-155, 2014.

M. Sène, J. M. Taylor, J. J. Dignam, H. Jacqmin-gadda, and C. Proust-lima, Individualized dynamic prediction of prostate cancer recurrence with and without the initiation of a second treatment: Development and validation, Statistical Methods in Medical Research, vol.25, issue.6, pp.1-20, 2014.
DOI : 10.1177/0962280214535763

S. B. Shappell, J. Fulmer, D. Arguello, B. S. Wright, J. R. Oppenheimer et al., PCA3 Urine mRNA Testing for Prostate Carcinoma: Patterns of Use by Community Urologists and Assay Performance in Reference Laboratory Setting, Urology, vol.73, issue.2, pp.363-368, 2009.
DOI : 10.1016/j.urology.2008.08.459

S. F. Shariat, A. Semjonow, H. Lilja, C. Savage, A. J. Vickers et al., Tumor markers in prostate cancer I: Blood-based markers, Acta Oncologica, vol.360, issue.6, pp.61-75, 2011.
DOI : 10.1200/JCO.2004.09.142

M. R. Sharma, M. L. Maitland, and M. J. Ratain, RECIST: No Longer the Sharpest Tool in the Oncology Clinical Trials Toolbox--Point, Cancer Research, vol.72, issue.20, pp.5145-5149, 2012.
DOI : 10.1158/0008-5472.CAN-12-0058

L. Sheiner and S. Beal, NONMEM version 5.1. University of California, NONMEM Project Group, 1998.

L. B. Sheiner, B. Rosenberg, and K. L. Melmon, Modelling of individual pharmacokinetics for computer-aided drug dosage, Computers and Biomedical Research, vol.5, issue.5, pp.441-459, 1972.
DOI : 10.1016/0010-4809(72)90051-1

R. L. Siegel, K. D. Miller, and A. Jemal, Cancer statistics, 2016, Cancer statistics, pp.7-30, 2016.
DOI : 10.1111/obr.12321

M. Simeoni, P. Magni, C. Cammia, D. Nicolao, G. Croci et al., Predictive Pharmacokinetic-Pharmacodynamic Modeling of Tumor Growth Kinetics in Xenograft Models after Administration of Anticancer Agents, Cancer Research, vol.64, issue.3, pp.1094-1101, 2004.
DOI : 10.1158/0008-5472.CAN-03-2524

E. H. Slate and B. W. Turnbull, Statistical models for longitudinal biomarkers of disease onset, Statistics in Medicine, vol.86, issue.11, pp.617-637, 2000.
DOI : 10.1002/(SICI)1097-0258(20000229)19:4<617::AID-SIM360>3.0.CO;2-R

L. H. Sobin, M. K. Gospodarowicz, and C. Wittekind, TNM classification of malignant tumours, 2011.
DOI : 10.1002/0471463752

X. Song, M. Davidian, and A. A. Tsiatis, A Semiparametric Likelihood Approach to Joint Modeling of Longitudinal and Time-to-Event Data, Biometrics, vol.57, issue.4, pp.742-753, 2002.
DOI : 10.1111/j.0006-341X.2002.00742.x

S. Development and T. , Stan modeling language users guide and reference manual

W. D. Stein, J. L. Gulley, J. Schlom, R. A. Madan, W. Dahut et al., Tumor Regression and Growth Rates Determined in Five Intramural NCI Prostate Cancer Trials: The Growth Rate Constant as an Indicator of Therapeutic Efficacy, Clinical Cancer Research, vol.17, issue.4, pp.907-917, 2011.
DOI : 10.1158/1078-0432.CCR-10-1762

A. J. Stephenson, M. W. Kattan, J. A. Eastham, Z. A. Dotan, F. J. Bianco et al., Defining Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy: A Proposal for a Standardized Definition, Journal of Clinical Oncology, vol.24, issue.24, pp.3973-3978, 2006.
DOI : 10.1200/JCO.2005.04.0756

E. W. Steyerberg, A. J. Vickers, N. R. Cook, T. Gerds, M. Gonen et al., Assessing the Performance of Prediction Models, Epidemiology, vol.21, issue.1, pp.2010-128
DOI : 10.1097/EDE.0b013e3181c30fb2

F. Subtil and M. Rabilloud, Robust non-linear mixed modelling of longitudinal PSA levels after prostate cancer treatment, Statistics in Medicine, vol.39, issue.2, pp.573-587, 2010.
DOI : 10.1016/S0167-9473(01)00057-3
URL : https://hal.archives-ouvertes.fr/hal-00539437

M. J. Sweeting and S. G. Thompson, Joint modelling of longitudinal and time-to-event data with application to predicting abdominal aortic aneurysm growth and rupture, Biometrical Journal, vol.27, issue.5, pp.750-763, 2011.
DOI : 10.1002/bimj.201100052

I. F. Tannock, R. De-wit, W. R. Berry, J. Horti, A. Pluzanska et al., Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer, New England Journal of Medicine, vol.351, issue.15, pp.1502-1512, 2004.
DOI : 10.1056/NEJMoa040720

J. M. Taylor, Y. Park, D. P. Ankerst, C. Proust-lima, S. Williams et al., Real-Time Individual Predictions of Prostate Cancer Recurrence Using Joint Models, Biometrics, vol.103, issue.1, pp.206-213, 2013.
DOI : 10.1111/j.1541-0420.2012.01823.x

J. M. Taylor, J. Shen, E. H. Kennedy, L. Wang, and D. E. Schaubel, Comparison of methods for estimating the effect of salvage therapy in prostate cancer when treatment is given by indication, Statistics in Medicine, vol.38, issue.3, pp.257-274, 2014.
DOI : 10.1002/sim.5890

J. M. Taylor and Y. Wang, Surrogate markers and joint models for longitudinal and survival data, Controlled Clinical Trials, vol.23, issue.6, pp.626-634, 2002.
DOI : 10.1016/S0197-2456(02)00234-9

J. M. Taylor, M. Yu, and H. M. Sandler, Individualized Predictions of Disease Progression Following Radiation Therapy for Prostate Cancer, Journal of Clinical Oncology, vol.23, issue.4, pp.816-825, 2005.
DOI : 10.1200/JCO.2005.12.156

P. Therasse, S. G. Arbuck, E. A. Eisenhauer, J. Wanders, R. S. Kaplan et al., New Guidelines to Evaluate the Response to Treatment in Solid Tumors, JNCI: Journal of the National Cancer Institute, vol.92, issue.3, pp.205-216, 2000.
DOI : 10.1093/jnci/92.3.205

A. Tsiatis, V. Degruttola, and M. Wulfsohn, Modeling the Relationship of Survival to Longitudinal Data Measured with Error. Applications to Survival and CD4 Counts in Patients with AIDS, Journal of the American Statistical Association, vol.9, issue.429, pp.27-37, 1995.
DOI : 10.1080/01621459.1995.10476485

A. A. Tsiatis and M. Davidian, Joint modeling of longitudinal and time-to-event data : an overview, Statistica Sinica, vol.14, pp.809-834, 2004.

H. Tu, S. C. Jacobs, A. Borkowski, and N. Kyprianou, Incidence of apoptosis and cell proliferation in prostate cancer: Relationship with TGF-??1 and bcl-2 expression, International Journal of Cancer, vol.69, issue.5, pp.357-363, 1996.
DOI : 10.1002/(SICI)1097-0215(19961021)69:5<357::AID-IJC1>3.0.CO;2-4

S. Ueckert, M. K. Rivière-jourdan, and F. Mentré, Evaluation of the Fisher information matrix in nonlinear mixed effect models without linearization. PODE : Population Optimum Design of Experiments, 2015.

H. Uno, T. Cai, M. J. Pencina, R. B. D-'agostino, and L. Wei, On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data, Statistics in Medicine, vol.81, issue.2, pp.1105-1117, 2011.
DOI : 10.1002/sim.4154

H. Van-houwelingen and H. Putter, Dynamic prediction in clinical survival analysis, 2011.

M. Vigan, Modélisation de données longitudinales et de données d'événements répétés par des modèles non linéaires à effets mixtes : application à la maladie de Gaucher, 2014.

E. F. Vonesh, A note on the use of Laplace's approximation for nonlinear mixed-effects models, Biometrika, vol.83, issue.2, pp.447-452, 1996.
DOI : 10.1093/biomet/83.2.447

Y. Wang and J. M. Taylor, Jointly Modeling Longitudinal and Event Time Data With Application to Acquired Immunodeficiency Syndrome, Journal of the American Statistical Association, vol.96, issue.455, pp.895-905, 2001.
DOI : 10.1198/016214501753208591

M. Wilbaux, M. Tod, D. Bono, J. Lorente, D. Mateo et al., A Joint Model for the Kinetics of CTC Count and PSA Concentration During Treatment in Metastatic Castration-Resistant Prostate Cancer, CPT: Pharmacometrics & Systems Pharmacology, vol.3, issue.suppl; abstract, pp.277-285, 2015.
DOI : 10.1002/psp4.34

R. Wolfinger, Laplace's approximation for nonlinear mixed models, Biometrika, vol.80, issue.4, pp.791-795, 1993.
DOI : 10.1093/biomet/80.4.791

L. Wu, W. Liu, G. Y. Yi, and Y. Huang, Analysis of Longitudinal and Survival Data: Joint Modeling, Inference Methods, and Issues, Journal of Probability and Statistics, vol.57, issue.1, p.2012, 2011.
DOI : 10.1214/009053605000000480

M. S. Wulfsohn and A. A. Tsiatis, A Joint Model for Survival and Longitudinal Data Measured with Error, Biometrics, vol.53, issue.1, pp.330-339, 1997.
DOI : 10.2307/2533118

W. Ye, X. Lin, and J. M. Taylor, Semiparametric Modeling of Longitudinal Measurements and Time-to-Event Data-A Two-Stage Regression Calibration Approach, Biometrics, vol.93, issue.4, pp.1238-1246, 2008.
DOI : 10.1111/j.1541-0420.2007.00983.x

B. You, P. Perrin, G. Freyer, A. Ruffion, B. Tranchand et al., Advantages of prostate-specific antigen (PSA) clearance model over simple PSA half-life computation to describe PSA decrease after prostate adenomectomy, Clinical Biochemistry, vol.41, issue.10-11, pp.785-795, 2008.
DOI : 10.1016/j.clinbiochem.2008.04.001
URL : https://hal.archives-ouvertes.fr/hal-00756369

M. Yu, N. J. Law, J. M. Taylor, and H. M. Sandler, Joint longitudinal-survival-cure models and their application to prostate cancer, Statistica Sinica, pp.835-862, 2004.

M. Yu, J. M. Taylor, and H. M. Sandler, Individual Prediction in Prostate Cancer Studies Using a Joint Longitudinal Survival???Cure Model, Journal of the American Statistical Association, vol.103, issue.481, pp.178-187, 2008.
DOI : 10.1198/016214507000000400

G. K. Zagars and A. Pollack, Kinetics of serum prostate-specific antigen after external beam radiation for clinically localized prostate cancer, Radiotherapy and Oncology, vol.44, issue.3, pp.213-221, 1997.
DOI : 10.1016/S0167-8140(97)00123-0

L. Zhang, S. L. Beal, and L. B. Sheiner, Simultaneous vs. Sequential Analysis for Population PK/PD Data I: Best-Case Performance, Journal of Pharmacokinetics and Pharmacodynamics, vol.30, issue.6, pp.387-404, 2003.
DOI : 10.1023/B:JOPA.0000012998.04442.1f